
Ebene Regina Haycroft
@ebenerhaycroft
Scientist at The Peter Doherty Institute for Infection and Immunity 🦠
ID: 1460394635256156162
15-11-2021 23:50:11
49 Tweet
61 Takipçi
103 Takip Edilen



Another piece of work from my phd and from Ebene Regina Haycroft masters thesis is finally out! Read it here 👇 key points are broken down in this 🧵 #COVID19 #phdlife #Researchpaper #Antibodies link.springer.com/article/10.100…


Great study by Ebene Regina Haycroft I Am Dr. Sam 👩🔬 exploring how different mutations in SARS-CoV2 RBD influence ACE-2 binding and escape antibody functions. Great explanation of study below Kevin John 🧪🧩 The Viral and Vaccine Immunology Lab Wai-Hong Tham


Congratulations to I Am Dr. Sam 👩🔬 for her SARS-CoV2 IgA paper being awarded the 2022 CTI Clinical & Translational Immunology Publication of the year! Thanks to many collaborators including Wai-Hong Tham The Viral and Vaccine Immunology Lab Kevin John 🧪🧩 Ebene Regina Haycroft Doherty Institute

BCG vaccine’s off-target effect on herpes simplex virus. Results from the international 🇦🇺🇳🇱🇬🇧🇪🇸🇧🇷 #BRACEtrial published today show a beneficial effect of BCG on cold sore recurrence. sciencedirect.com/science/articl… #BCG #vaccine #RCT #HSV #IDTwitter #WeAreID eClinicalMedicine – The Lancet Discovery Science


New research shows mucosal surfaces in eyes, nose, mouth and throat are crucial to the first line of defence against upper respiratory infections, like #COVID19. Published in JCI insight ICB - the journal doherty.edu.au/news-events/ne… UniMelb MDHS The Royal Melbourne Hospital Kevin John 🧪🧩

How do #mucosal antibodies respond after #vaccination or #covid breakthrough infection? 🤔 Do previous exposures shape future #humoral responses? Our work is finally out as twin publications in JCI insight and ICB - the journal Short🧵to follow 😉



Check out this great work by Ebene Regina Haycroft and co. looking at antibody glycosylation in the humoral response to SIV-TB coinfection in 🐒👇

Great work by Ebene Regina Haycroft that demonstrates how antibody glycosylation early in SIV-TB infection is a biomarker for TB disease progression Doherty Institute UniMelb MDHS